ScienceDex / Researcher record
Upendra Marathi
- 7 Hills Pharma, LLC (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2024
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $3M in linked award amounts across 3 award records · Award-linked rank #2685.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9297425Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2024 award records by amount
NIH award records listing Upendra Marathi as a PI. Multi-PI records show the full award amount for context.
- 5R44CA285207-02R44Contact PI7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors$999.2Kaward amount
- 5R44AI172437-03R44Contact PIIntegrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection$997.9Kaward amount
- 5R44AI176894-02R44Contact PI7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination$953.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing Upendra Marathi as a PI.
FY2024 award administered by 7 Hills Pharma, LLC (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH Award7 Hills Pharma, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2685
- 2024Entered Top 25% NationallyRanked #2685
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Upendra Marathi.